A new study published in Engineering offers insights into nonlinear meta-devices. Conducted by researchers from the City ...

Initiation of dosing in our Phase 1b clinical trial represents an important step in the clinical development of GT-02287 and in Gain’s mission to deliver a disease-modifying therapy to people with ...

Abstract: Metasurfaces can degrade radar pulse compression (PC) performance by encoding radar echoes with time-domain random phase modulation (RPM), which alters the correlation between the echo ...

Gain Therapeutics (GANX) announced the dosing of the first participant with Parkinson’s disease in its Phase 1b clinical trial of GT-02287, the ...

Three innovative design techniques substantially enhance wireless transmitter performance and can boost power efficiency and elevate data rates concurrently, as reported by the researchers from ...

Interim Analysis Expected End of 2Q 2025 BETHESDA, MD / ACCESS Newswire / March 14, 2025 / Gain Therapeutics, Inc. (Nasdaq:GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company lead ...

Recent advances in nonlinear meta-devices are explored, focusing on their role in nanophotonics and strategies for enhancing ...

Privately-held US drugmaker Tris Pharma today announced positive top-line results from its ALLEVIATE-2 Phase III pivotal ...

Meanwhile, the amplitude of the jamming signal suffers from the modulation of sine functions, which causes a waste of jamming energy. Against the above problems, this article introduces a ...

A new study reveals how scientists made history by turning light into a supersolid, marking a major breakthrough in physics.